MEDICINOVA INC
For the period ended Dec 31, 2024. Filed Feb 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 19, 2025
MNOV$1.40-4.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
| Common stock · Additionalpaid-in · Accumulatedothercomprehensive · Accumulated · Totalstockholders’ | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | capital | loss | deficit | equity | |
| Balance at December 31, 2022 | 49,046,246 | $49,046 | $477,438,451 | $(115,285) | $(407,130,177) | $70,242,035 |
| Share-based compensation | — | — | 710,710 | — | — | 710,710 |
| Net loss | — | — | — | — | (8,571,516) | (8,571,516) |
| Foreign currency translation adjustments | — | — | — | (2,805) | — | (2,805) |
| Balance at December 31, 2023 | 49,046,246 | 49,046 | 478,149,161 | (118,090) | (415,701,693) | 62,378,424 |
| Share-based compensation | — | — | 1,191,740 | — | — | 1,191,740 |
| Net loss | — | — | — | — | (11,049,549) | (11,049,549) |
| Foreign currency translation adjustments | — | — | — | (17,064) | — | (17,064) |
| Balance at December 31, 2024 | 49,046,246 | $49,046 | $479,340,901 | $(135,154) | $(426,751,242) | $52,503,551 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.